*Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders.

*Norditroin® - over 25 years of countinuing commitment to growth hormone therapy through device development and indication expansion.

*For Japanese HCPs, in the exhibition hall , we are going providing a demonstration of “Norditropin® FlexPro® ” and “ PenNeedle® Plus” which is going to be launched in Dec 2016.